Ikoma, Japan

Takashi Nagano

USPTO Granted Patents = 11 

 

 

Average Co-Inventor Count = 3.0

ph-index = 3

Forward Citations = 16(Granted Patents)


Location History:

  • Nara, JP (2015)
  • Ikoma, JP (2014 - 2018)
  • Saga, JP (2019 - 2023)
  • Osaka, JP (2016 - 2024)

Company Filing History:


Years Active: 2014-2025

Loading Chart...
Loading Chart...
Loading Chart...
11 patents (USPTO):

Title: **The Innovations of Takashi Nagano: A Key Contributor to Dry Eye Treatments**

Introduction

Takashi Nagano is a prominent inventor located in Ikoma, Japan, known for his contributions to the field of pharmaceuticals, particularly in the treatment of dry eye conditions. With a total of 8 patents to his name, his work has significantly impacted the way we understand and treat this prevalent eye condition.

Latest Patents

Among his notable patents are two innovative medicaments designed for preventing and treating dry eye. These compounds are formulated to not substantially impact intraocular pressure, addressing a common concern in conventional treatments. One of his latest patents outlines a method whereby a therapeutically effective amount of olodaterol, or a salt thereof, is administered to subjects in need, highlighting a targeted approach to dry eye management.

Career Highlights

Throughout his career, Takashi Nagano has collaborated with esteemed pharmaceutical companies. Notably, he has worked with Santen Pharmaceutical Co., Ltd. and Boehringer Ingelheim International Gmbh. His expertise in medicinal chemistry and his innovative mindset have driven advancements in therapeutic options available for dry eye sufferers.

Collaborations

In addition to his corporate affiliations, Takashi has worked alongside notable colleagues such as Masatsugu Nakamura and Kazutaka Kido. These collaborations have further propelled his research and innovation efforts in developing effective pharmaceutical solutions.

Conclusion

Takashi Nagano’s dedication and innovative spirit have established him as a noteworthy inventor in the pharmaceutical landscape. His contributions, particularly to the treatment of dry eye, exemplify the impact of focused research and collaboration within the industry. As advancements in medical science continue, the work of innovators like Nagano will remain integral to enhancing patient care and treatment options.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…